Abstract

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2

Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald

Issue: May/Jun 2007 - Pain Management

Page(s): 220-225

Download in electronic PDF format for $75
  • Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 1
  • Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 2
  • Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 3
  • Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 4
  • Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 5
  • Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Page 6

Abstract

The development and compounding of pharmacotherapeutic formulations that are suitable for infants and young children can be a challenging problem. This problem results from the lack of knowledge on the acceptability of different dosage forms and formulations to children in relation to age and developmental status, as well as the lack of reliable documentation of formulations used in pediatric clinical trials. As part of its mandate under the Best Pharmaceuticals for Children Act to improve pediatric therapeutics, the National Institute of Child Health and Human Development has sponsored the Pediatric Formulations Initiative. The goal of this ongoing initiative is to address the issues and concerns associated with pediatric therapeutics by convening groups of researchers and experts in pediatric formulations from academia, pharmaceutical companies, the National Institutes of Health, and the U.S. Food and Drug Administration. In this second part of a two-part article, the activities of the various groups that c

Related Keywords

  • children
  • pediatric formulations
  • oral dosage forms
  • NICHD
  • liquid formulations
  • Biopharmaceutical Classification System
  • patient compliance
  • flavoring
  • palatability
  • drug costs
  • drug taste
  • fast-dissolving preparations

Related Categories

  • LEGAL
  • PAIN MANAGEMENT
  • PEDIATRICS
  • PATIENT COMPLIANCE
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Jan/Feb 2001
Pg. 9-12
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Author(s): Schotik Debora
Sep/Oct 2006
Pg. 390
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 410
Prescription: Pediatric Formulation Initiatives
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 456-461
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Author(s): Fonseca Simonne C
Jul/Aug 1999
Pg. 274-276
Extemporaneous Formulations in Pediatric Patients
Author(s): Nahata Milap C
Jan/Feb 2007
Pg. 17-19
Pediatric Oral Formulations: A Continual Challenge
Author(s): Hurtado Josephine, Moffett Brady S
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
May/Jun 2016
Pg. 257-261
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Jul/Aug 2008
Pg. 365-367
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
May/Jun 2016
Pg. 247-249
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Author(s): Nahata Milap C
Mar/Apr 1997
Pg. 84-86
Compounding for the Pediatric Patient
Author(s): Allen Loyd V Jr
Jan/Feb 2009
Pg. 14-18
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2011
Pg. 32-40
Maillard Reactions in Pharmaceutical Formulations and Human Health
Author(s): Newton David W
Sep/Oct 2010
Pg. 401-405
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 1
Author(s): Evans Alex, Haile Michael, Anderson Kim
Mar/Apr 2012
Pg. 104-109
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 2
Author(s): Haile Michael, Anderson Kim, Evans Alex, Crawford Angela